Stay updated with breaking news from Into contracts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Following the completion of the spin-off of the Upjohn Business (4) in the fourth quarter of 2020, Pfizer now operates as a focused innovative biopharmaceutical company engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products worldwide. Revenues and expenses associated with the Upjohn Business (4) for first-quarter 2020 have been recategorized as discontinued operations and excluded from Adjusted (2) results. Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business (4) in the first three quarters of 2020 , is now included within the Hospital therapeutic area for all periods presented. ....